Literature DB >> 11579307

Risk factors for chronic rejection after pediatric liver transplantation.

P Gupta1, J Hart, D Cronin, S Kelly, J M Millis, L Brady.   

Abstract

BACKGROUND: Chronic rejection is a major cause of graft failure and a frequent reason for retransplantation after pediatric liver transplantation. Identification of risk factors for chronic rejection in pediatric transplant recipients is vital to understanding the pathogenesis of chronic rejection and may help prevent further graft loss.
METHODS: The study population consisted of 285 children with 385 liver transplants performed at University of Chicago between 1991 and 1999. Logistic regression analysis was used to evaluate risk factors for chronic rejection, including age, sex, race, type of graft (living related vs. cadaveric), native liver disease, acute rejection episodes, cytomegalovirus (CMV) infection, and posttransplant lymphoproliferative disease (PTLD).
RESULTS: The chronic rejection rate was significantly lower in recipients of living-related grafts than in recipients of cadaveric grafts (4% vs. 16%, P=0.001). African-American recipients had a significantly higher rate of chronic rejection than did Caucasian recipients (26% vs. 8%, P<0.001). Numbers of acute rejection episodes, transplantation for autoimmune disease, occurrence of PTLD, and CMV infection were also significant risk factors for chronic rejection. However, recipient age, gender, donor-recipient gender mismatch, and donor-recipient ethnicity mismatch were not associated with higher incidence of chronic rejection
CONCLUSION: We have identified a number of risk factors for chronic rejection in a large group of pediatric liver allograft recipients. We believe that donor-recipient matching for gender or race is not likely to reduce the incidence of chronic rejection. The elucidation of the mechanisms by which living-related liver transplantation affords protection against chronic rejection may provide insight into the immunogenetics of chronic rejection and help prevent further graft loss.

Entities:  

Mesh:

Year:  2001        PMID: 11579307     DOI: 10.1097/00007890-200109270-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation.

Authors:  Emanuele Nicastro; Sara Giovannozzi; Paola Stroppa; Valeria Casotti; Anna Paola Callegaro; Alessandra Tebaldi; Claudio Farina; Michele Colledan; Lorenzo DʼAntiga
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.

Authors:  Karen C Tsai; Lara A Danziger-Isakov; David B Banach
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

3.  Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain.

Authors:  Jon D Reuter; Daniel L Gomez; Jean H Wilson; Anthony N Van Den Pol
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 4.  Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?

Authors:  Sandy Feng
Journal:  Curr Opin Organ Transplant       Date:  2008-10       Impact factor: 2.640

Review 5.  Therapy for acute rejection in pediatric organ transplant recipients.

Authors:  Dominique Debray; Válerie Furlan; Véronique Baudouin; Lucile Houyel; Florence Lacaille; Christophe Chardot
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes.

Authors:  Rekha V Thammana; Stuart J Knechtle; Rene Romero; Thomas G Heffron; Caroline T Daniels; Rachel E Patzer
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

Review 7.  Strategies for optimizing immunosuppression in adolescent transplant recipients: a focus on liver transplantation.

Authors:  Deirdre A Kelly
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.930

8.  Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation.

Authors:  Ana Cristina Aoun Tannuri; Fabiana Lima; Evandro Sobroza de Mello; Ryan Yukimatsu Tanigawa; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2016-04       Impact factor: 2.365

9.  Pediatric Liver Transplantation Program at the Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

Authors:  Ana Cristina Aoun Tannuri; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2016-04       Impact factor: 2.365

10.  Cytomegalovirus Infection under a Hybrid Strategy in Pediatric Liver Transplantation: A Single-Center Experience.

Authors:  Ryung Kim; Dai Joung; Sunghee Lee; Insook Jeong; Seak Hee Oh; Jung-Man Namgoong; Dae Yeon Kim; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.